Business · 26/08/2020Updated: 10/17/2026 · 1 min read
FDA Announces Joint Meeting of Drug Safety and Risk Management Advisory Committee and Anesthetic and Analgesic Drug Products Advisory Committee
Summary
The FDA is hosting a joint meeting of its advisory committees to provide advice on regulatory issues, with the public invited to attend and submit comments on proposed regulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →